Showing results (151-160 of 184) with videos related to
Sort By:
Pageof 19
Revista Da Associacao Medica Brasileira (1992)|February 15, 2001
[Prevalence of thyroid nodules in 40 years-old or old women]T W Furlanetto, S Peccin, M A de O Schneider, et al.Life Sciences|May 30, 2025
The impact of preexisting omega-3 fatty acid serum levels on outcomes following out-of-hospital cardiac arrest: A comprehensive investigationJ Grabert, G Mohsen, C Diepenseifen, et al.Journal for Immunotherapy of Cancer|July 27, 2019
A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analysesAlexandra S Zimmer, Erin Nichols, Ashley Cimino-Mathews, et al.Neurobiology of Disease|August 6, 2022
Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsyAlessia Salamone, Gaetano Terrone, Rossella Di Sapia, et al.The Oncologist|June 6, 2023
A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial CarcinomaSarah L P Atkins, Yoshimi Endo Greer, Sarah Jenkins, et al.Life Sciences|September 12, 2020
Parameters predicting COVID-19-induced myocardial injury and mortalityG D Duerr, A Heine, M Hamiko, et al.Neuropathology and Applied Neurobiology|December 24, 2019
Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformationsT S Zimmer, G Ciriminna, A Arena, et al.Epilepsia|December 14, 2021
Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesionsVictoria-Elisabeth Gruber, Mark J Luinenburg, Katrin Colleselli, et al.Frontiers in Cellular Neuroscience|December 13, 2023
Loss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytesMark J Luinenburg, Mirte Scheper, Frederik N F Sørensen, et al.Neuropathology and Applied Neurobiology|May 18, 2021
Balloon cells promote immune system activation in focal cortical dysplasia type 2bTill S Zimmer, Diede W M Broekaart, Mark Luinenburg, et al.Pageof 19